Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Driving ability in chronic pain patients on long-term opioid analgesics
NL-OMON29168Recruiting
- Sponsor
- Bundesanstalt für Straßenwesen
- Start
- Nov 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of fentanyl, buprenorphine, oxycodone, oxycodone + naloxone, hydromorphone and 3 more in Chronic non-cancer pain (CNCP) (2 arms), sponsored by Bundesanstalt für Straßenwesen. Primary endpoint: Standard Deviation of Lateral Position. Started Nov 2009; status: recruiting.
02
Drugs
fentanylbuprenorphineoxycodoneoxycodone + naloxonehydromorphone
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on NL-OMON29168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29168.